I wouldn't expect that to stay stable any more than doing the lifetime cost calculations for HIV initially and today. Cancers are increasingly being survived, u

I wouldn't expect that to stay stable any more than doing the lifetime cost calculations for HIV initially and today. Cancers are increasingly being survived, usually with at least some additional lifelong health care requirements (which pharma will always be looking to expand upon) on top of the costs for a healthy individual.